StockCIK 1563880

Trevi Therapeutics, Inc. (TRVI): Insider Trades and Fund Holdings

In the past 12 months, Trevi Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 1 sale worth $596K; 1 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$596KSold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 17, 2026.

Recent TRVI insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 17	Sep 15	Michael Thomas HeffernanDirector	Director	▼ SELL10b5-1	39,473	15.09	$596K	−86%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Michael Thomas Heffernan	Director	0	$0	1	$596K	Sep 17, 2026

Tracked funds that report TRVI

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Viking Global Investors	Q2 2026	1,544,644	$28.8M	0.08%	▼ −51.7%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →